Clinical impact of PTEN methylation status as a prognostic marker for breast cancer
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
2090-5920
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Clinical impact of PTEN methylation status as a prognostic marker for breast cancer ; volume:19 ; number:1 ; day:10 ; month:5 ; year:2021 ; pages:1-11 ; date:12.2021
Journal of Genetic Engineering and Biotechnology ; 19, Heft 1 (10.5.2021), 1-11, 12.2021
- Creator
-
Ramadan, Amal
Hashim, Maha
Abouzid, Amr
Swellam, Menha
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1186/s43141-021-00169-4
- URN
-
urn:nbn:de:101:1-2021091120254957118508
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:26 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Ramadan, Amal
- Hashim, Maha
- Abouzid, Amr
- Swellam, Menha
- SpringerLink (Online service)
Other Objects (12)
Prognostic DNA methylation markers for hormone receptor breast cancer: a systematic review
High PTEN gene expression is a negative prognostic marker in human primary breast cancers with preserved p53 function
PCMT1 as a prognostic marker in breast cancer
Prognostic DNA methylation markers for sporadic colorectal cancer: a systematic review
An assessment of prognostic immunity markers in breast cancer
Identifying prognostic markers in spatially heterogeneous breast cancer microenvironment
Roadmap of DNA methylation in breast cancer identifies novel prognostic biomarkers
Prognostic and immune correlation of IDO1 promoter methylation in breast cancer
Alterations of PTEN and SMAD4 methylation in diagnosis of breast cancer: implications of methyl II PCR assay
Small breast epithelial mucin as a useful prognostic marker for breast cancer patients
RECK is not an independent prognostic marker for breast cancer
Cathepsin B: a potential prognostic marker for inflammatory breast cancer
Prognostic DNA methylation markers for hormone receptor breast cancer: a systematic review
High PTEN gene expression is a negative prognostic marker in human primary breast cancers with preserved p53 function
PCMT1 as a prognostic marker in breast cancer
Prognostic DNA methylation markers for sporadic colorectal cancer: a systematic review
An assessment of prognostic immunity markers in breast cancer
Identifying prognostic markers in spatially heterogeneous breast cancer microenvironment
Roadmap of DNA methylation in breast cancer identifies novel prognostic biomarkers
Prognostic and immune correlation of IDO1 promoter methylation in breast cancer
Alterations of PTEN and SMAD4 methylation in diagnosis of breast cancer: implications of methyl II PCR assay
Small breast epithelial mucin as a useful prognostic marker for breast cancer patients
RECK is not an independent prognostic marker for breast cancer
Cathepsin B: a potential prognostic marker for inflammatory breast cancer
Prognostic DNA methylation markers for hormone receptor breast cancer: a systematic review
High PTEN gene expression is a negative prognostic marker in human primary breast cancers with preserved p53 function
PCMT1 as a prognostic marker in breast cancer
Prognostic DNA methylation markers for sporadic colorectal cancer: a systematic review
An assessment of prognostic immunity markers in breast cancer
Identifying prognostic markers in spatially heterogeneous breast cancer microenvironment
Roadmap of DNA methylation in breast cancer identifies novel prognostic biomarkers
Prognostic and immune correlation of IDO1 promoter methylation in breast cancer
Alterations of PTEN and SMAD4 methylation in diagnosis of breast cancer: implications of methyl II PCR assay
Small breast epithelial mucin as a useful prognostic marker for breast cancer patients
RECK is not an independent prognostic marker for breast cancer